GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (FRA:Q8T) » Definitions » ROA %

OrbusNeich Medical Group Holdings (FRA:Q8T) ROA % : 9.20% (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is OrbusNeich Medical Group Holdings ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. OrbusNeich Medical Group Holdings's annualized Net Income for the quarter that ended in Jun. 2024 was €35.1 Mil. OrbusNeich Medical Group Holdings's average Total Assets over the quarter that ended in Jun. 2024 was €381.0 Mil. Therefore, OrbusNeich Medical Group Holdings's annualized ROA % for the quarter that ended in Jun. 2024 was 9.20%.

The historical rank and industry rank for OrbusNeich Medical Group Holdings's ROA % or its related term are showing as below:

FRA:Q8T' s ROA % Range Over the Past 10 Years
Min: -2.39   Med: 7.07   Max: 11.86
Current: 9.48

During the past 6 years, OrbusNeich Medical Group Holdings's highest ROA % was 11.86%. The lowest was -2.39%. And the median was 7.07%.

FRA:Q8T's ROA % is ranked better than
86.41% of 868 companies
in the Medical Devices & Instruments industry
Industry Median: -1.415 vs FRA:Q8T: 9.48

OrbusNeich Medical Group Holdings ROA % Historical Data

The historical data trend for OrbusNeich Medical Group Holdings's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrbusNeich Medical Group Holdings ROA % Chart

OrbusNeich Medical Group Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROA %
Get a 7-Day Free Trial 6.78 -2.44 6.14 11.68 9.63

OrbusNeich Medical Group Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.63 13.76 10.12 9.20 10.01

Competitive Comparison of OrbusNeich Medical Group Holdings's ROA %

For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrbusNeich Medical Group Holdings's ROA % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's ROA % distribution charts can be found below:

* The bar in red indicates where OrbusNeich Medical Group Holdings's ROA % falls into.



OrbusNeich Medical Group Holdings ROA % Calculation

OrbusNeich Medical Group Holdings's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=41.332/( (331.401+376.102)/ 2 )
=41.332/353.7515
=11.68 %

OrbusNeich Medical Group Holdings's annualized ROA % for the quarter that ended in Jun. 2024 is calculated as:

ROA %=Net Income (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=35.066/( (376.102+385.939)/ 2 )
=35.066/381.0205
=9.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Jun. 2024) net income data. ROA % is displayed in the 30-year financial page.


OrbusNeich Medical Group Holdings  (FRA:Q8T) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jun. 2024 )
=Net Income/Total Assets
=35.066/381.0205
=(Net Income / Revenue)*(Revenue / Total Assets)
=(35.066 / 146.614)*(146.614 / 381.0205)
=Net Margin %*Asset Turnover
=23.92 %*0.3848
=9.20 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


OrbusNeich Medical Group Holdings ROA % Related Terms

Thank you for viewing the detailed overview of OrbusNeich Medical Group Holdings's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


OrbusNeich Medical Group Holdings Business Description

Traded in Other Exchanges
Address
3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG
OrbusNeich is a China-based global medical device maker of endovascular interventional instruments with global reach. It launched its first research base in 2001 and was listed on the Hong Kong Exchange in 2022. As of 2023, OrbusNeich's largest revenue segment by geography is Japan with 24.7% of total revenue followed by Europe, the Middle East, and Africa, with 23.6% of total revenue. The Asia-Pacific region and the United States make up the balance. Its largest product segment is coronary interventional medical devices, such as scoring balloons, non-compliant balloons, or stents, together representing 82.7% of its total revenue.

OrbusNeich Medical Group Holdings Headlines

No Headlines